On the federal channel "Russia 1" on the air of the program "On the main thing" the most important topic of the development of the coronavirus COVID-19 using DHQ is revealed.


Use of Dihydroquercetin in COVID-19. VGTRK Rossiya broadcast, February 14, 2022  


The Vesti website highlights a 2007 US Department of Defense-funded study on DHA-mediated reduction of infection susceptibility.

"Dihydroquercetin at the threat of coronavirus: truth or fiction"


The main news site in Ukraine tells about a new drug based on quercitin, which can help in the fight against COVID-19, because has an anti-inflammatory effect.